Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant derivative of C3 transferase

EU orphan designation number: EU/3/08/563   
Active ingredient: Recombinant derivative of C3 transferase
Indication: Treatment of traumatic spinal cord injury
Sponsor: Vertex Pharmaceuticals (U.K.) Limited
Cardinal Point, Park Road, Rickmansworth, Herts WD3 1RE, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/09/2008 Orphan designation EMEA/OD/012/08 (2008)5024 of 05/09/2008
23/01/2014 Change of address of sponsor
27/01/2015 Transfer of orphan designation EMA/OD/012/08/T/01 (2015)415 of 23/01/2015